Vericel Net Profit Margin 2010-2024 | VCEL

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Vericel net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Vericel net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.

Related Stocks
Company Name	Market Cap
Amgen (AMGN)	$171.6B
Vertex Pharmaceuticals (VRTX)	$129B
Bristol Myers Squibb (BMY)	$113.5B
Gilead Sciences (GILD)	$112.3B
CSL (CSLLY)	$91.7B
Regeneron Pharmaceuticals (REGN)	$91.1B
GSK (GSK)	$76.7B
Argenex SE (ARGX)	$36B
Alnylam Pharmaceuticals (ALNY)	$34.2B
BioNTech SE (BNTX)	$26.4B
Biogen (BIIB)	$25.8B
Illumina (ILMN)	$24.7B
Moderna (MRNA)	$20.5B
BeiGene (BGNE)	$20.3B
Genmab (GMAB)	$15.1B
Incyte (INCY)	$14.9B
Exact Sciences (EXAS)	$13.2B
BioMarin Pharmaceutical (BMRN)	$12.6B
Insmed (INSM)	$12.4B
Bio-Techne Corp (TECH)	$12.3B
Vaxcyte (PCVX)	$12B
Sarepta Therapeutics (SRPT)	$11.9B
QIAGEN (QGEN)	$10B
Exelixis (EXEL)	$9.9B
Revolution Medicines (RVMD)	$9.5B
Intra-Cellular Therapies (ITCI)	$9.5B
Bio-Rad Laboratories (BIO.B)	$9.4B
Roivant Sciences (ROIV)	$8.6B
Repligen (RGEN)	$8.2B
Legend Biotech (LEGN)	$8.1B